Assertion: sorafenib tosylate ethanol solvate | /r/HasProperty | obtained
Facets:
value: preferentially
type: MANNER
value: according to the disclosure of document
type: OTHER
value: alone
type: MANNER
Source sentences:
text: The comparative data presented were fair, and it was believed that the toluene solvate mentioned in Table II of the application as filed was obtained according to the disclosure of document (1).
text: At a high supersaturation, the crystallization process is dominated by kinetic factors and only the ethanol solvate is obtained.
text: The ethanol solvate was obtained alone when the concentration of the solution was above 0.0097, and the concomitant crystals of form II and the ethanol solvate were observed when the concentration was between 0.0094 and 0.0097 at 313.15 K. Both the needle-like and transparent prism morphologies were observed in the optical microscope images shown in Fig. 2 .
text: When the supersaturation is high enough, kinetic factors will dominate the crystallization process, and the ethanol solvate may be obtained preferentially.
text: Sorafenib tosylate ethanol solvate is obtained.
text: Sorafenib tosylate ethanol solvate is obtained.